Please use this identifier to cite or link to this item:
https://hdl.handle.net/10419/45003
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Conlé, Marcus | en |
dc.date.accessioned | 2010-11-25 | - |
dc.date.accessioned | 2011-04-19T12:34:17Z | - |
dc.date.available | 2011-04-19T12:34:17Z | - |
dc.date.issued | 2010 | - |
dc.identifier.uri | http://hdl.handle.net/10419/45003 | - |
dc.description.abstract | Biotechnology is one of the knowledge fields particularly targeted by China, as it is considered to open up windows of opportunity for catch-up to the leading economies. However, the seizing of these opportunities requires the existence of an institutional and organizational structure supportive of the introduction and usage of biotechnological knowledge. The present contribution discusses this problem in its national, regional, and sectoral dimensions. By focusing on the biopharmaceutical sector, it is shown that the regulatory environment and the capital market constitute serious bottlenecks to further development. | en |
dc.language.iso | eng | en |
dc.publisher | |aUniversity of Duisburg-Essen, Institute of East Asian Studies (IN-EAST) |cDuisburg | en |
dc.relation.ispartofseries | |aDuisburg Working Papers on East Asian Studies |x87/2010 | en |
dc.subject.ddc | 330 | en |
dc.subject.keyword | China | en |
dc.subject.keyword | health biotechnology | en |
dc.subject.keyword | innovation system | en |
dc.subject.keyword | pharmaceutical | en |
dc.title | Health biotechnology in China: National, regional, and sectoral dimensions | - |
dc.type | Working Paper | en |
dc.identifier.ppn | 640609481 | en |
dc.rights | http://www.econstor.eu/dspace/Nutzungsbedingungen | en |
dc.identifier.repec | RePEc:zbw:udedao:872010 | en |
Files in This Item:
Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.